Cargando…
The NLRP3 inflammasome and COVID-19: Activation, pathogenesis and therapeutic strategies
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), exhibits a wide spectrum of clinical presentations, ranging from asymptomatic cases to severe pneumonia or even death. In severe COVID-19 cases, an increased level of proinflammatory cytokine...
Autores principales: | Zhao, Ni, Di, Bin, Xu, Li-li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233448/ https://www.ncbi.nlm.nih.gov/pubmed/34183243 http://dx.doi.org/10.1016/j.cytogfr.2021.06.002 |
Ejemplares similares
-
NLRP3 inflammasome activation contributes to the pathogenesis of cardiocytes aging
por: Liao, Li-Zhen, et al.
Publicado: (2021) -
Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023) -
Chronic kidney disease and NLRP3 inflammasome: Pathogenesis, development and targeted therapeutic strategies
por: Huang, Gengzhen, et al.
Publicado: (2022) -
Focus on the Role of the NLRP3 Inflammasome in Multiple Sclerosis: Pathogenesis, Diagnosis, and Therapeutics
por: Cui, Yueran, et al.
Publicado: (2022) -
Relevance of the NLRP3 Inflammasome in the Pathogenesis of Chronic Liver Disease
por: Wu, Xiaoqin, et al.
Publicado: (2017)